Munafa Stock Market Course + Intraday & FNO calls 
Moleculin Biotech (MBRX) Technical (Analysis) Reports Moleculin Biotech ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Moleculin Biotech (MBRX)
Technical Analysis Report for USA stock MBRX Moleculin Biotech. Dated: 08 Jan 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock MBRX Moleculin Biotech then click here. or read Experts views on Moleculin Biotech or Forecast & share price targets of Moleculin Biotech
Moleculin Biotech Opened at 4.07 and Closed at: 4.11, which is 0.97% of previous session's close. It moved within a range of 4.05 and 4.34
The session was a Bullish session with an average volume of 109900, which is -51.41% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
Support for tomorrow is 4.08 and resistance for tomorrow is 4.37
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 3.99, 3.88 resistance for tomorrow's hourly charts is 4.28, 4.46
10 Day SMA for Moleculin Biotech (MBRX) is 3.76 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Moleculin Biotech (MBRX) is 4.08 and the stock is trading above these levels. This is a good sign for its mid term trend
50 Day SMA for Moleculin Biotech (MBRX) is 2.83 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 1.64 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Moleculin Biotech is 1.2 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Moleculin Biotech is at 4.08 and 200 DMA is at 1.2, while 50 DMA and 100 DMA are at 2.83 and 1.64 respectively
Moleculin Biotech (MBRX) moving average of 20 SMA is at 4.08 and 20 EMA is at 3.92
| Date | Closing Price | 20 SMA | 20 EMA |
| 08 Thu Jan | 4.11 | 4.08 | 3.92 |
| 07 Wed Jan | 4.07 | 4.21 | 3.9 |
| 06 Tue Jan | 4.12 | 4.37 | 3.88 |
| 05 Mon Jan | 3.90 | 4.52 | 3.86 |
| 02 Fri Jan | 3.62 | 4.71 | 3.86 |
| 31 Wed Dec | 3.31 | 4.91 | 3.88 |
Moleculin Biotech (MBRX) moving average of 50 SMA is at 2.83 and 50 EMA is at 3.16
| Date | Closing Price | 50 SMA | 50 EMA |
| 08 Thu Jan | 4.11 | 2.83 | 3.16 |
| 07 Wed Jan | 4.07 | 2.75 | 3.12 |
| 06 Tue Jan | 4.12 | 2.68 | 3.08 |
| 05 Mon Jan | 3.90 | 2.61 | 3.04 |
| 02 Fri Jan | 3.62 | 2.54 | 3 |
| 31 Wed Dec | 3.31 | 2.48 | 2.97 |
Moleculin Biotech (MBRX) moving average of 100 SMA is at 1.64 and 100 EMA is at 2.32
| Date | Closing Price | 100 SMA | 100 EMA |
| 08 Thu Jan | 4.11 | 1.64 | 2.32 |
| 07 Wed Jan | 4.07 | 1.61 | 2.28 |
| 06 Tue Jan | 4.12 | 1.58 | 2.24 |
| 05 Mon Jan | 3.90 | 1.54 | 2.2 |
| 02 Fri Jan | 3.62 | 1.51 | 2.17 |
| 31 Wed Dec | 3.31 | 1.48 | 2.14 |
Moleculin Biotech (MBRX) moving average of 200 SMA is at 1.2 and 200 EMA is at 1.81
| Date | Closing Price | 200 SMA | 200 EMA |
| 08 Thu Jan | 4.11 | 1.2 | 1.81 |
| 07 Wed Jan | 4.07 | 1.19 | 1.79 |
| 06 Tue Jan | 4.12 | 1.17 | 1.77 |
| 05 Mon Jan | 3.90 | 1.16 | 1.75 |
| 02 Fri Jan | 3.62 | 1.15 | 1.73 |
| 31 Wed Dec | 3.31 | 1.13 | 1.71 |
Moleculin Biotech has performed better than Arcus Biosciences in short term. Holding Moleculin Biotech could be a better choice for now!
Cardinal Health has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Cardinal Health, about 17.07% more returns!
Urogen Pharma has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Urogen Pharma, about 20.68% more returns!
Neuronetics Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Neuronetics Inc, about 62.28% more returns!
Riot Blockchain has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Riot Blockchain, about 12.08% more returns!
Rigel Pharmaceuticals has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Rigel Pharmaceuticals, about 23.01% more returns!
Oncolytics Biotech has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Oncolytics Biotech, about 14.91% more returns!
Medpace Holdings has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Medpace Holdings, about 21.91% more returns!
Lifevantage Corporation has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Lifevantage Corporation, about 10.25% more returns!
Icon Plc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Icon Plc, about 16.18% more returns!
Hutchison China has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Hutchison China, about 22.09% more returns!
Exelixis Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Exelixis Inc, about 22.41% more returns!
Caredx Inc has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Caredx Inc, about 2.99% more returns!
Bioxcel Therapeutics has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Bioxcel Therapeutics, about 6.23% more returns!
Aquestive Therapeutics has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Aquestive Therapeutics, about 14.43% more returns!
Apyx Medical has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Apyx Medical, about 0.77% more returns!
Moleculin Biotech has performed better than Angiodynamics Inc in short term. Holding Moleculin Biotech could be a better choice for now!
Akebia Therapeutics has performed better than Moleculin Biotech in short term. You could have earned much better returns by investing in Akebia Therapeutics, about 6.32% more returns!
Moleculin Biotech has performed better than Aclaris Therapeutics in short term. Holding Moleculin Biotech could be a better choice for now!
Moleculin Biotech Technical analysis of indicators
Price action analysis of Moleculin Biotech (MBRX) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Moleculin Biotech stock for short term is BUY. Signal strength is Strong and stock is gaining momentum.
MACD generated a SELL signal for Moleculin Biotech in short term but the sell signal is initial and weak.
Moleculin Biotech Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Moleculin Biotech in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Moleculin Biotech is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.73 and Moleculin Biotech MBRX stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Moleculin Biotech MBRX stock. Volume based technical analysis of Moleculin Biotech MBRX stock is negative.
Moleculin Biotech Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock MBRX Moleculin Biotech These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And MBRX Experts View which covers a lot of information including buying and selling signals
MBRX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Moleculin Biotech or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Moleculin Biotech (MBRX) Technical (Analysis) Reports Moleculin Biotech ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance
